PATRICIA
LOPEZ SUAREZ
Profesora Titular de Universidad
ANA MARIA
SUAREZ DIAZ
Catedrática de Universidad
Publicacions en què col·labora amb ANA MARIA SUAREZ DIAZ (78)
2023
-
Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages
Rheumatology (Oxford, England), Vol. 62, Núm. 8, pp. 2898-2907
-
Immunometabolic Profile Associated with Progressive Damage of the Intestinal Mucosa in Adults Screened for Colorectal Cancer: Association with Diet
International Journal of Molecular Sciences, Vol. 24, Núm. 22
2021
-
Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis
Arthritis and Rheumatology, Vol. 73, Núm. 3, pp. 401-413
2020
-
Erratum: Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus (Rheumatology (2020) 59 (1752-1764) DOI: 10.1093/rheumatology/keaa016)
Rheumatology (United Kingdom)
-
Glyca levels during the earliest stages of rheumatoid arthritis: Potential use as a biomarker of subclinical cardiovascular disease
Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-19
-
IgM anti-phosphorylcholine antibodies associate with senescent and IL-17+ T cells in SLE patients with a pro-inflammatory lipid profile
Rheumatology (Oxford, England), Vol. 59, Núm. 2, pp. 407-417
-
Low-density granulocytes and monocytes as biomarkers of cardiovascular risk in systemic lupus erythematosus
Rheumatology (Oxford, England), Vol. 59, Núm. 7, pp. 1752-1764
2019
-
Clinical and subclinical cardiovascular disease in female SLE patients: Interplay between body mass index and bone mineral density
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 29, Núm. 2, pp. 135-143
-
IRF4 and IRGS delineate clinically relevant gene expression signatures in systemic lupus erythematosus and rheumatoid arthritis
Frontiers in Immunology, Vol. 10, Núm. JAN
-
Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis
Scientific Reports, Vol. 9, Núm. 1
2018
-
Anti-high-density lipoprotein antibodies and antioxidant dysfunction in immune-driven diseases
Frontiers in Medicine, Vol. 5, Núm. APR
-
Anti-high-density lipoprotein antibodies and antioxidant dysfunction in immune-driven diseases
Frontiers in Medicine, Vol. 5, Núm. APR
-
Could Fecal Phenylacetic and Phenylpropionic Acids Be Used as Indicators of Health Status?
Journal of Agricultural and Food Chemistry, Vol. 66, Núm. 40, pp. 10438-10446
-
Endothelial progenitor cells as mediators of the crosstalk between vascular repair and immunity: Lessons from systemic autoimmune diseases
Current Medicinal Chemistry, Vol. 25, Núm. 35, pp. 4478-4496
-
Heterogeneity of the type I interferon signature in rheumatoid arthritis: A potential limitation for its use as a clinical biomarker
Frontiers in Immunology, Vol. 8, Núm. JAN
-
Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes
Frontiers in immunology, Vol. 9, pp. 2351
-
The role of gut microbiota in lupus: what we know in 2018?
Expert Review of Clinical Immunology, Vol. 14, Núm. 10, pp. 787-792
2017
-
Circulating microparticle subpopulations in systemic lupus erythematosus are affected by disease activity
International Journal of Cardiology, Vol. 236, pp. 138-144
-
High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein
Journal of Clinical Lipidology, Vol. 11, Núm. 4, pp. 1043-1054.e2
-
Intestinal dysbiosis is associated with altered short-chain fatty acids and serum-free fatty acids in systemic lupus erythematosus
Frontiers in Immunology, Vol. 8, Núm. JAN